|
|
|
|
 |
|||
|
|||
Islet morphogenesis and stem cell markers in rat pancreas
L Bouwens and E De Blay
Department of Experimental Pathology, Free University Brussels, Belgium.
During embryonic development, and possibly also later in life, pancreatic islets of Langerhans originate from differentiating epithelial stem cells. These stem cells are situated in the pancreatic ducts but are otherwise poorly characterized. We found by immunohistochemical staining that protodifferentiated pancreatic epithelial cells from rat embryos of Day 13-Day 15 express the cytoskeletal protein keratin 20, similar to mature duct epithelium. During the period of islet morphogenesis, which occurs between Day 17 and birth, large aggregates of K20-positive duct cells were formed, which gradually differentiated into endocrine cells. This islet morphogenic mechanism has not been described thus far and we did not observe it in postnatal rats. During fetal islet formation, transient expression of vimentin was noted in the duct cells but not in endocrine cells. This intermediate filament protein is not observed in duct epithelial cells after birth. The proto-oncogene product bcl-2, a putative epithelial stem cell marker, was detected in duct cells from fetal and postnatal pancreas. We conclude that K20, vimentin, and bcl-2 are markets for the pancreatic (islet) stem cells.
Volume 44,
Issue 9,
pp. 947-951,
09/01/1996
Copyright © 1996 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  U. Ganapati, H. T. Tan, M. Lynch, M. Dolezal, S. de Vos, and J. C. Gasson Modeling Notch Signaling in Normal and Neoplastic Hematopoiesis: Global Gene Expression Profiling in Response to Activated Notch Expression Stem Cells, August 1, 2007; 25(8): 1872 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bouwens and I. Rooman Regulation of Pancreatic Beta-Cell Mass Physiol Rev, October 1, 2005; 85(4): 1255 - 1270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Banaei-Bouchareb, V. Gouon-Evans, D. Samara-Boustani, M. C. Castellotti, P. Czernichow, J. W. Pollard, and M. Polak Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice J. Leukoc. Biol., August 1, 2004; 76(2): 359 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Gelling, X. Q. Du, D. S. Dichmann, J. Romer, H. Huang, L. Cui, S. Obici, B. Tang, J. J. Holst, C. Fledelius, et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice PNAS, February 4, 2003; 100(3): 1438 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Regoli, D. Orazioli, R. Gerli, and E. Bertelli Glial Fibrillary Acidic Protein (GFAP)-like Immunoreactivity in Rat Endocrine Pancreas J. Histochem. Cytochem., February 1, 2000; 48(2): 259 - 266. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Schmied, G. Liu, M.P. Moyer, I.S.B. Hernberg, W. Sanger, S. Batra, and P. M. Pour Induction of adenocarcinoma from hamster pancreatic islet cells treated with N-nitrosobis(2-oxopropyl)amine in vitro Carcinogenesis, February 1, 1999; 20(2): 317 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-I. Ohtani, H. Shimizu, N. Sato, and M. Mori Troglitazone (CS-045) Inhibits {beta}-Cell Proliferation Rate Following Stimulation of Insulin Secretion in HIT-T 15 Cells Endocrinology, January 1, 1998; 139(1): 172 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jackerott and L.-I. Larsson Immunocytochemical Localization of the NPY/PYY Y1 Receptor in the Developing Pancreas Endocrinology, November 1, 1997; 138(11): 5013 - 5018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Scaglia, C. J. Cahill, D. T. Finegood, and S. Bonner-Weir Apoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat Endocrinology, April 1, 1997; 138(4): 1736 - 1741. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |